Vanguard Group Inc. boosted its holdings in shares of KKR & Co. Inc. (NYSE:KKR – Free Report) by 0.8% during the 4th quarter, Holdings Channel reports. The firm owned 56,687,516 shares of the asset manager’s stock after buying an additional 441,817 shares during the period. Vanguard Group Inc. owned about 0.06% of KKR & Co. Inc. worth $8,384,650,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. State Street Corp raised its stake in KKR & Co. Inc. by 1.8% during the 3rd quarter. State Street Corp now owns 26,703,762 shares of the asset manager’s stock valued at $3,486,977,000 after purchasing an additional 481,686 shares during the period. Wellington Management Group LLP raised its stake in KKR & Co. Inc. by 0.3% during the 3rd quarter. Wellington Management Group LLP now owns 23,432,827 shares of the asset manager’s stock valued at $3,059,859,000 after purchasing an additional 60,147 shares during the period. Geode Capital Management LLC raised its stake in KKR & Co. Inc. by 2.7% during the 3rd quarter. Geode Capital Management LLC now owns 13,589,852 shares of the asset manager’s stock valued at $1,768,788,000 after purchasing an additional 355,837 shares during the period. FMR LLC raised its stake in KKR & Co. Inc. by 1.5% during the 3rd quarter. FMR LLC now owns 11,251,333 shares of the asset manager’s stock valued at $1,469,199,000 after purchasing an additional 165,631 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its stake in KKR & Co. Inc. by 2.3% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 3,772,331 shares of the asset manager’s stock valued at $557,965,000 after purchasing an additional 85,461 shares during the period. Institutional investors own 76.26% of the company’s stock.
Wall Street Analyst Weigh In
A number of research firms have issued reports on KKR. Keefe, Bruyette & Woods reduced their price objective on KKR & Co. Inc. from $170.00 to $168.00 and set an “outperform” rating on the stock in a research note on Monday, January 13th. Morgan Stanley reduced their price objective on KKR & Co. Inc. from $157.00 to $156.00 and set an “equal weight” rating on the stock in a research note on Thursday, February 6th. HSBC downgraded KKR & Co. Inc. from a “buy” rating to a “hold” rating and lifted their price objective for the stock from $153.00 to $173.00 in a research note on Thursday, January 30th. Wells Fargo & Company raised KKR & Co. Inc. from an “equal weight” rating to an “overweight” rating and reduced their price objective for the stock from $150.00 to $141.00 in a research note on Thursday. Finally, Hsbc Global Res downgraded KKR & Co. Inc. from a “strong-buy” rating to a “hold” rating in a research note on Thursday, January 30th. One analyst has rated the stock with a sell rating, three have given a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $160.79.
KKR & Co. Inc. Price Performance
KKR opened at $116.54 on Monday. The business has a fifty day moving average of $139.07 and a 200 day moving average of $141.64. KKR & Co. Inc. has a 52-week low of $91.92 and a 52-week high of $170.40. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.82. The stock has a market cap of $103.52 billion, a P/E ratio of 35.00, a PEG ratio of 1.00 and a beta of 1.72.
KKR & Co. Inc. Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, February 28th. Investors of record on Friday, February 14th were issued a dividend of $0.175 per share. This represents a $0.70 dividend on an annualized basis and a yield of 0.60%. The ex-dividend date of this dividend was Friday, February 14th. KKR & Co. Inc.’s payout ratio is currently 21.02%.
Insiders Place Their Bets
In other KKR & Co. Inc. news, major shareholder Genetic Disorder L.P. Kkr sold 6,000,000 shares of the company’s stock in a transaction on Wednesday, March 5th. The stock was sold at an average price of $32.96, for a total value of $197,760,000.00. Following the completion of the sale, the insider now directly owns 19,260,971 shares in the company, valued at approximately $634,841,604.16. This represents a 23.75 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 39.34% of the company’s stock.
KKR & Co. Inc. Company Profile
KKR & Co, Inc operates as an investment firm. It offers alternative asset management as well as capital markets and insurance solutions. The firm’s business segments include Asset Management and Insurance Business. The Asset Management segment engages in providing private equity, real assets, credit and liquid strategies, capital markets, and principal activities.
Recommended Stories
- Five stocks we like better than KKR & Co. Inc.
- How to invest in marijuana stocks in 7 stepsĀ
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- How to Effectively Use the MarketBeat Ratings Screener
- 3 ETFs to Ride the VIX Surge During Market Volatility
- What Are the U.K. Market Holidays? How to Invest and Trade
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Want to see what other hedge funds are holding KKR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for KKR & Co. Inc. (NYSE:KKR – Free Report).
Receive News & Ratings for KKR & Co. Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KKR & Co. Inc. and related companies with MarketBeat.com's FREE daily email newsletter.